Schedule

The Critical Care Pharmacy Preparatory Review Course will be held Saturday and Sunday, April 25-26, 2020.

Click below for the full meeting schedule.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 25-26, 2020

Critical Care Pharmacy Preparatory Review and Recertification Course -- Audio Recorded Topics - Pharmacokinetics/Pharmacodynamics, Practice Management: Medication Safety and Pharmacoeconomics, History of Critical Care and Professional Development, and Policy, Practice, and Regulatory Issues

Monday, April 29, 2019

Available for 4.25 hours of CPE credit
Activity Number: 0217-0000-19-087-H01-P

The following topics will be recorded and made available to participants of the course by July 1, 2019. These recorded topics are included in your meeting registration at no additional charge.
Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development

Speakers
Faculty: Curtis E. Haas, Pharm.D., FCCP, BCPS
Director of Pharmacy, University of Rochester Medical Center, Rochester, New York
View Biography
Curtis E. Haas, Pharm.D., FCCP, BCPS
Haas
Faculty: Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM, BCPS
Professor of Clinical Pharmacy and Translational Science Associate Dean for Strategic Initiatives and Operations The University of Tennessee College of Pharmacy Memphis, Tennessee
View Biography
Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM, BCPS
Boucher

Learning Objectives
1. Describe key landmark events in the evolution of critical care pharmacy as a specialty.
2. Summarize key published documents and evidence validating critical care pharmacy as a specialty for validation to other health care professionals and stakeholders.
3. List the core knowledge areas for pharmacists caring for critically ill patients.
4. Identify the elements of fundamental, desirable, and optimal pharmacist practice and pharmacy service components.
5. Summarize the findings from key studies documenting the association of critical care pharmacy services with favorable health care outcomes.
6. List the criteria for credentialing and training of pharmacists providing ritical care services at the desired and optimal levels as outlined in the 2011 American College of Clinical Pharmacy (ACCP) critical care “PRN Opinion Paper,” in addition to critical care training opportunities and growth.
7. Apply the standards of practice for clinical pharmacy to the critical care practice environment using a standard process of care.
8. Develop an approach to conducting a gap analysis relative to the principles and values of team-based care in a local critical care practice environment.
9. Differentiate between the conventional and nontraditional pathways of training to obtain knowledge, skills, and attitudes for critical care pharmacy practice.
10. Define the key features of a mentor-mentee (protégé) relationship and the important role of mentoring in developing and training critical care clinical pharmacists.
11. Develop an approach to lifelong professional learning to maintain competency in critical care pharmacy practice using the principles of continuing professional development.
12. Identify the many educational components or techniques that can be incorporated into a personal development plan.
13. Identify the avenues and processes for contributing to the critical care body of knowledge as a presenter, author, or peer reviewer.
Pharmacokinetics/Pharmacodynamics

Speakers
Faculty: Joseph M. Swanson, Joseph M. Swanson, Pharm.D., FCCM, FCCP, BCPS
Associate Professor of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis, Tennessee
View Biography
Joseph M. Swanson, Joseph M. Swanson, Pharm.D., FCCM, FCCP, BCPS
Swanson

Learning Objectives
1. Describe the changes in critically ill patients that alter drug absorption.
2. Explain how critical illness affects drug distribution.
3. Depict the effects of changing hepatic blood flow, intrinsic activity, and protein binding on drug metabolism.
4. Differentiate between different critically ill patient populations and the expected pharmacokinetic (PK) changes.
5. Incorporate the PK changes in a critically ill patient into the design and evaluation of an appropriate drug regimen.
6. Identify the desired pharmacodynamic variables associated with efficacy in select drugs.
Practice Management: Medication Safety and Pharmacoeconomics

Speakers
Faculty: Sandra L. Kane-Gill, Pharm.D., M.Sc., FCCP, FCCM
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh, School of Pharmacy, Pittsburgh, Pennsylvania
View Biography
Sandra L. Kane-Gill, Pharm.D., M.Sc., FCCP, FCCM
Kane-Gill

Learning Objectives
1. Review pharmacoeconomic principles and their application to patient care.
2. Compare a medication error, an adverse drug event (ADE), an adverse drug reaction, and a preventable ADE.
3. Design an ADE reporting program, including committee structure, committee reporting mechanisms, and methods of detecting, reporting, and managing ADEs.
4. Outline the recommendations in the safe medication use guidelines for the ICU.
Describe the safety measures for drug interaction detection and prevention.
6. Develop and implement a drug formulary proposal.